Connect Sign In
2008426
SLCO1B1, 1 Variant
SLCO1B1
Ordering Recommendation
Identify individuals at increased risk for statin-related muscle toxicity.
New York DOH Approval Status
This test is New York state approved.
Specimen Required
Patient Preparation
Collect
Lavender (EDTA) or pink (K2EDTA), or yellow (ACD Solution A or B).
Specimen Preparation
Transport 3 mL whole blood. (Min: 1 mL)
Storage/Transport Temperature
Refrigerated.
Unacceptable Conditions
Plasma or serum. Heparinized specimens. Frozen specimens in glass collection tubes.
Remarks
Stability
Ambient: 72 hours; Refrigerated: 1 week; Frozen: 1 month
Methodology
Polymerase Chain Reaction (PCR)/Fluorescence Monitoring
Performed
Mon, Thu
Reported
5-10 days
Reference Interval
By report
Interpretive Data
Refer to report.
Compliance Category
Laboratory Developed Test (LDT)
Note
Hotline History
Hotline History
Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
N/A
CPT Codes
81328
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 2008427 | SLCO1B1, 1 Variant, Specimen | 66746-9 |
| 2008428 | SLCO1B1, 1 Variant,*5 Genotype | 93412-5 |
| 3016893 | EER SLCO1B1 | 11526-1 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
- Simvastatin myotoxicity assay
- Statin-induced myopathy assay
SLCO1B1, 1 Variant
